Evidence map›Paper›PMID 41584415›Full record

ArticleCurrent health sciences journal

The GaMBK Anastomosis: A Novel and Simplified Technique for Pancreaticojejunostomy.

Sergio Isidro Gamboa-Hoil, Ricardo Gamboa-Gutiérrez, Alejandro Medina-Campos

Abstract read
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sergio Isidro Gamboa-HoilSurgical Oncology, Unidad Médica de Alta Especialidad, Instituto Mexicano del Seguro Social, Mérida, Yucatán, Mexico.
Ricardo Gamboa-GutiérrezSurgical Oncology, Unidad Médica de Alta Especialidad, Instituto Mexicano del Seguro Social, Mérida, Yucatán, Mexico.
Alejandro Medina-CamposDepartment of Research, Unidad Médica de Alta Especialidad, Instituto Mexicano del Seguro Social, Mérida, Yucatán, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe present a modification of the Blumgart and Kakita techniques, which we call GaMBK (Gamboa-Modified Blumgart and Kakita) anastomosis. Our primary objective was to evaluate the association between clinically relevant postoperative pancreatic fistula (POPF, grades B/C) and the type of pancreaticojejunal anastomosis performed during pancreaticoduodenectomy (GaMBK vs Blumgart).

methodsFrom June 2021 to June 2022, the Blumgart anastomosis was performed, and from July 2022 to March 2024, the GaMBK technique was implemented. A total of 38 patients (15 men and 23 women) who underwent pancreaticoduodenectomy for malignant disease were included in this historical cohort study.

resultsThe median pancreatic duct diameter was 3mm in both the GaMBK and Blumgart groups (p=0.79). Median drain amylase levels were 38 U/L (range 30-1200) in the GaMBK group and 34U/L (range 30-3263) in the Blumgart group (p=0.40). Clinically relevant POPF occurred in 8.7% of the GaMBK group and 6.7% of the Blumgart group (p=1). All cases were grade B, and no grade C fistulas were identified. Median hospital stay was 7 days for the GaMBK group and 6 days for the Blumgart group. No association was found between the GaMBK technique and an increased risk of POPF (RR 1.304; 95% CI: 0.129-13.149; p=0.66).

conclusionThe GaMBK anastomosis is a technically simpler modification of the Blumgart and Kakita techniques that does not increase the risk of clinically relevant POPF.

Indexed as

Blumgart techniqueGaMBK anastomosisKakita techniquepancreaticoduodenectomypostoperative pancreatic fistula

Identifiers

PMID41584415
PMCPMC12831546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.